To protect 340B providers in the Medicaid program

The bill prevents restrictions on hospitals' access to discounted prescription drugs under the Medicaid program, as allowed by federal law. It requires prior notification and reporting if any limitations are to be proposed, explaining the details, anticipated savings, and impacts on hospitals. Certain high-cost drugs may still be restricted, specifically those costing over $100,000 or certain designated drugs.

Supporters would highlight that this bill ensures hospitals maintain access to crucial drug discounts under the 340B program, allowing them to provide better care to patients without incurring additional costs. They might also emphasize the transparency and accountability required before any restrictions are implemented, which protects hospitals financially.

Critics might argue that the bill limits the state's ability to control Medicaid spending by preserving a broad access to discounted drugs, potentially leading to higher overall costs. They could also point out the potential for loopholes in how drug restrictions and fiscal impacts are reported and mitigated.